Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Protea Biosciences (PRGB)

Protea Biosciences (PRGB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Protea Biosciences 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505 USA

www.proteabio.com P: 304-292-2226

Description:

Protea Biosciences Group, Inc. is a commercial stage molecular information company. It offers proprietary life science technologies, products, and services that are used to identify, characterize and quantify biologically important molecules for basic research, pharmaceutical development and diagnostic applications. The Company's commercial offering includes the LAESI DP-1000 instrument system and its ProteaWorks mass spec imaging services unit. It has also developed, internally, the software platform ProteaPlot to address other limitations of mass spectrometry. Protea Biosciences Group, Inc. is based in Morgantown, West Virginia.

Key Statistics

Overview:

Market Capitalization, $K 279
Shares Outstanding, K 7,970
Annual Sales, $ 2,440 K
Annual Net Income, $ -15,640 K
Last Quarter Sales, $ 330 K
Last Quarter Net Income, $ -5,500 K
60-Month Beta -2.48
% of Insider Shareholders 31.90%
% of Institutional Shareholders 3.39%

Growth:

1-Year Return -99.42%
3-Year Return -99.89%
5-Year Return 0.00%
5-Year Revenue Growth 245.07%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 12/11/17
Earnings Per Share ttm -3.00
EPS Growth vs. Prev Qtr -100.00%
EPS Growth vs. Prev Year -100.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 10/16/17

PRGB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -390.45%
Profit Margin % -640.98%
Debt/Equity -0.12
Price/Sales 0.18
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.50
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar